Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019002914) NEW STRAIN OF LACTOBACILLUS REUTERI WITH PROBIOTIC CHARACTERISTICS, ITS USE AND COMPOSITIONS CONTAINING SAID STRAIN
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS

1. A strain of Lactobacillus reuteri No. LMG P-27481 deposited with the center of collection of microorganisms BCCM/LMG Bacteria Collection of the Gent University (Belgium).

2. The strain according to claim 1 for use as medicament.

3. The strain according to claim 1 or 2 for use in the treatment of diarrhoeal infections.

4. The strain according to claim 3, wherein said diarrhoeal infections are induced by Clostridium difficile.

5. Pharmaceutical compositions comprising the strain as claimed in at least one of claims 1 to 4 and pharmaceutically tolerable additives.

6. The compositions according to claim 5 for use in the treatment of diarrhoeal infections.

7. The compositions according to claim 6, wherein said diarrhoeal infections are induced by Clostridium difficile.

8. Medical devices comprising the strain as claimed in at least one of claims 1 to 3 and additives used in the field.

9. Medical devices according to claim 8 for use in the treatment of diarrhoeal infections.

10. Devices according to claim 9, wherein said diarrhoeal infections are induced by Clostridium difficile.

1 1. Food supplements useful in the treatment of diarrhoeal infections comprising the strain as claimed in at least one of claims 1 to 4 and additives usually used in the nutraceutical field.

12. Food supplements according to claim 9, wherein said diarrhoeal infections are induced by Clostridium difficile.